Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 1
1991 1
1992 1
1993 4
1994 3
1995 11
1996 7
1997 6
1998 6
1999 3
2000 2
2001 4
2002 2
2003 1
2005 2
2006 6
2008 5
2009 3
2010 3
2011 3
2012 5
2013 5
2014 1
2015 4
2016 4
2017 1
2018 2
2019 4
2020 9
2021 20
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 and cardiovascular disease.
Guijarro C. Guijarro C. Clin Investig Arterioscler. 2020 Nov-Dec;32(6):263-266. doi: 10.1016/j.arteri.2020.10.005. Clin Investig Arterioscler. 2020. PMID: 33213825 Free PMC article. English, Spanish. No abstract available.
Lipid-induced glomerular injury.
Guijarro C, Keane WF. Guijarro C, et al. Nephron. 1994;67(1):1-6. doi: 10.1159/000187881. Nephron. 1994. PMID: 8052348 Free article. Review. No abstract available.
SEA-SEACV 2015: Guía para el diagnóstico y tratamiento del aneurisma de aorta abdominal.
Lahoz C, Gracia CE, García LR, Montoya SB, Hernando ÁB, Heredero ÁF, Tembra MS, Velasco MB, Guijarro C, Ruiz EB, Pintó X, de Ceniga MV, Moñux Ducajú G; en representación del Grupo de Prevención Secundaria de la Sociedad Española de Arteriosclerosis y de la Sección de Medicina Vascular de la Sociedad Española de Angiología y Cirugía Vascular. Lahoz C, et al. Among authors: guijarro c. Clin Investig Arterioscler. 2016 Mar;28 Suppl 1:1-49. doi: 10.1016/S0214-9168(16)30026-2. Clin Investig Arterioscler. 2016. PMID: 27107212 Spanish. No abstract available.
COPD and cardiovascular disease: More than just a co-incidence.
Pena X, Guijarro C. Pena X, et al. Among authors: guijarro c. Rev Clin Esp (Barc). 2020 Jun-Jul;220(5):290-291. doi: 10.1016/j.rce.2019.10.007. Epub 2020 Jan 10. Rev Clin Esp (Barc). 2020. PMID: 31932046 English, Spanish. No abstract available.
Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease.
Pedro-Botet J, López-Miranda J, Badimón L, Civeira F, Guijarro C, Millán J, Mostaza JM, Pintó X, Valdivielso P, Masana L; Expert group from the Spanish Arteriosclerosis Society. Pedro-Botet J, et al. Among authors: guijarro c. Am J Cardiovasc Drugs. 2020 Aug;20(4):325-332. doi: 10.1007/s40256-019-00376-y. Am J Cardiovasc Drugs. 2020. PMID: 31650523 Review.
Estimation of vascular risk: Time and place matter.
Cuende JI, Guijarro C. Cuende JI, et al. Among authors: guijarro c. Rev Clin Esp (Barc). 2021 Dec;221(10):596-597. doi: 10.1016/j.rceng.2021.05.004. Epub 2021 Sep 22. Rev Clin Esp (Barc). 2021. PMID: 34563485 No abstract available.
Use of the cardiovascular polypill 40mg in secondary cardiovascular prevention.
Marzal D, Rodríguez Padial L, Arnáiz JA, Castro A, Cosín J, Lekuona I, Guijarro C. Marzal D, et al. Among authors: guijarro c. Clin Investig Arterioscler. 2018 Sep-Oct;30(5):240-247. doi: 10.1016/j.arteri.2018.04.004. Epub 2018 Jul 17. Clin Investig Arterioscler. 2018. PMID: 30017176 Review. English, Spanish.
125 results